Aspect Biosystems Presents New Preclinical Data on Adrenal Bioprinted Tissue Therapeutics at ENDO 2025

  • VANCOUVER, British Columbia--(BUSINESS WIRE)-- #biotech--Aspect Biosystems presents preclinical data showing potential of its adrenal BTTs to restore adrenal function and treat primary adrenal insufficiency.